Overactive Bladder - Results from #2400

Pharmacotherapy of overactive bladder: Epidemiology and pathophysiology of overactive bladder - Abstract April 19, 2011

Antimuscarinics for the treatment of overactive bladder: Understanding the role of muscarinic subtype selectivity - Abstract April 18, 2011

Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms - Abstract April 15, 2011

Development and pilot testing of a self-management internet-based program for older adults with overactive bladder - Abstract April 14, 2011

Urethral sphincter EMG-controlled dorsal penile/clitoral nerve stimulation to treat neurogenic detrusor overactivity - Abstract April 13, 2011

How does neuromodulation work: ICI-RS 2010? - Abstract April 12, 2011

Effect of fesoterodine 4 mg on bladder diary and patient-reported outcomes during the first week of treatment in subjects with overactive bladder - Abstract April 7, 2011

Etiology and pathogenesis of overactive bladder - Abstract April 4, 2011

Adherence junctions and cadherin-11 in normal and overactive human detrusor smooth muscle cells - Abstract April 1, 2011

Cost-effectiveness of sacral neuromodulation compared to botulinum neurotoxin A or continued medical management in refractory overactive bladder - Abstract March 28, 2011

Functional MRI of the brain in women with overactive bladder: Brain activation during urinary urgency - Abstract March 25, 2011

Adverse event assessment of antimuscarinics for treating overactive bladder: A network meta-analytic approach - Abstract March 24, 2011

TheraVida announces positive results from a phase 1 trial of THVD-201 for overactive bladder at the 2011 Annual Congress of the European Association of Urology March 24, 2011

Idiopathic Parkinson's disease patients at the urologic clinic - Abstract March 23, 2011

The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: Results from EpiLUTS - Abstract March 22, 2011

Long-term safety, tolerability, and efficacy of fesoterodine treatment in men and women with overactive bladder symptoms - Abstract March 21, 2011

Sacral neuromodulation with InterStim™ system: Results from the French National Register - Abstract March 18, 2011

Which single-item measures of overactive bladder symptom treatment correlate best with patient satisfaction? - Abstract March 17, 2011

Effect of caffeine on bladder function in patients with overactive bladder symptoms - Abstract March 15, 2011

PACS 2011 - Botulinum toxin for the treatment of overactive bladder - Session Highlights March 14, 2011

Page 121 of 122